ADMINISTRATION OF PHARMACEUTICALS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 19, 2001
app pub date -
Oct 21, 1997
filing date -
Jun 20, 1996
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A new administration regimen giving an extended plasma concentration profile of a H.sup.+, K.sup.+-ATPase inhibitor. The extended plasma profile is received by two or more consecutive administrations of a unit dose of a H.sup.+, K.sup.+-ATPase with 0.5-4 hours interval or by a pharmaceutical composition with extended release, which may be administered once daily.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully